We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 5,619 results
  1. Genetic prion diseases presenting as frontotemporal dementia: clinical features and diagnostic challenge

    Background

    To elucidate the clinical and ancillary features of genetic prion diseases (gPrDs) presenting with frontotemporal dementia (FTD) to aid...

    Zhongyun Chen, Min Chu, ... Liyong Wu in Alzheimer's Research & Therapy
    Article Open access 29 June 2022
  2. The E3 Ubiquitin Ligase TRAF6 Interacts with the Cellular Prion Protein and Modulates Its Solubility and Recruitment to Cytoplasmic p62/SQSTM1-Positive Aggresome-Like Structures

    The cellular prion protein (PrP C ) is a ubiquitous glycoprotein highly expressed in the brain where it is involved in neurite outgrowth, copper...

    Lara Masperone, Marta Codrich, ... Giuseppe Legname in Molecular Neurobiology
    Article 09 January 2022
  3. Role of sialylation of N-linked glycans in prion pathogenesis

    Mammalian prion or PrP Sc is a proteinaceous infectious agent that consists of a misfolded, self-replicating state of the prion protein or PrP C . PrP C ...

    Natallia Makarava, Ilia V. Baskakov in Cell and Tissue Research
    Article 28 January 2022
  4. Slow Virus and Prion Diseases

    Slow virus diseases are a large group of related neurodegenerative conditions which affect both humans and animals. The diseases are caused by a...
    Subhash Chandra Parija in Textbook of Microbiology and Immunology
    Chapter 2023
  5. Decrease in Skin Prion-Seeding Activity of Prion-Infected Mice Treated with a Compound Against Human and Animal Prions: a First Possible Biomarker for Prion Therapeutics

    Previous studies have revealed that the infectious scrapie isoform of prion protein (PrP Sc ) harbored in the skin tissue of patients or animals with...

    Mingxuan Ding, Kenta Teruya, ... Wen-Quan Zou in Molecular Neurobiology
    Article Open access 13 May 2021
  6. Prion-induced photoreceptor degeneration begins with misfolded prion protein accumulation in cones at two distinct sites: cilia and ribbon synapses

    Accumulation of misfolded host proteins is central to neuropathogenesis of numerous human brain diseases including prion and prion-like diseases....

    James F. Striebel, Brent Race, ... Bruce Chesebro in Acta Neuropathologica Communications
    Article Open access 29 January 2021
  7. Sporadic Creutzfeldt-Jakob disease VM1: phenotypic and molecular characterization of a novel subtype of human prion disease

    The methionine (M)—valine (V) polymorphic codon 129 of the prion protein gene ( PRNP ) plays a central role in both susceptibility and phenotypic...

    Ellen Gelpi, Simone Baiardi, ... Piero Parchi in Acta Neuropathologica Communications
    Article Open access 17 August 2022
  8. Prion type 2 selection in sporadic Creutzfeldt–Jakob disease affecting peripheral ganglia

    In sporadic Creutzfeldt–Jakob disease (sCJD), the pathological changes appear to be restricted to the central nervous system. Only involvement of the...

    Anna Hofmann, Arne Wrede, ... Walter J. Schulz-Schaeffer in Acta Neuropathologica Communications
    Article Open access 24 November 2021
  9. Extracellular vesicles with diagnostic and therapeutic potential for prion diseases

    Prion diseases (PrD) or transmissible spongiform encephalopathies (TSE) are invariably fatal and pathogenic neurodegenerative disorders caused by the...

    Arun Khadka, Jereme G. Spiers, ... Andrew F. Hill in Cell and Tissue Research
    Article Open access 08 April 2022
  10. Gene expression and epigenetic markers of prion diseases

    Epigenetics, meaning the variety of mechanisms underpinning gene regulation and chromatin states, plays a key role in normal development as well as...

    Emmanuelle A. Viré, Simon Mead in Cell and Tissue Research
    Article Open access 21 March 2022
  11. Pharmacological modulation of TSPO in microglia/macrophages and neurons in a chronic neurodegenerative model of prion disease

    Neuroinflammation is an important component of many neurodegenerative diseases, whether as a primary cause or a secondary outcome. For that reason,...

    Marta Vicente-Rodríguez, Renzo Mancuso, ... Diana Cash in Journal of Neuroinflammation
    Article Open access 09 April 2023
  12. Cell biology of prion strains in vivo and in vitro

    The properties of infectious prions and the pathology of the diseases they cause are dependent upon the unique conformation of each prion strain. How...

    Daniel Shoup, Suzette A. Priola in Cell and Tissue Research
    Article 02 February 2022
  13. Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation

    Prion diseases are caused by the propagation of PrP Sc , the pathological conformation of the PrP C prion protein. The molecular mechanisms underlying...

    Aline Bamia, Maha Sinane, ... Cécile Voisset in Neurotherapeutics
    Article 02 February 2021
  14. Organoids for modeling prion diseases

    Human cerebral organoids are an exciting and novel model system emerging in the field of neurobiology. Cerebral organoids are spheres of...

    Ryan O. Walters, Cathryn L. Haigh in Cell and Tissue Research
    Article 28 January 2022
  15. Volatile Anesthetic Sevoflurane Precursor 1,1,1,3,3,3-Hexafluoro-2-Propanol (HFIP) Exerts an Anti-Prion Activity in Prion-Infected Culture Cells

    Prion disease is a neurodegenerative disorder with progressive neurologic symptoms and accelerated cognitive decline. The causative protein of prion...

    Takuto Shimizu, Emiko Nogami, ... Naomi Hachiya in Neurochemical Research
    Article Open access 27 May 2021
  16. Cellular Prion Protein Attenuates OGD/R-Induced Damage by Skewing Microglia toward an Anti-inflammatory State via Enhanced and Prolonged Activation of Autophagy

    Modulation of microglial pro/anti-inflammatory states and autophagy are promising new therapies for ischemic stroke, but the underlying mechanisms...

    Jie Shao, **ang Yin, ... Li Cui in Molecular Neurobiology
    Article 28 November 2022
  17. Mutation of copper binding sites on cellular prion protein abolishes its inhibitory action on NMDA receptors in mouse hippocampal neurons

    We have previously reported that cellular prion protein (PrP C ) can down-regulate NMDA receptor activity and in a copper dependent manner. Here, we...

    Sun Huang, Stefanie A. Black, ... Gerald W. Zamponi in Molecular Brain
    Article Open access 19 July 2021
  18. A multiverse of α-synuclein: investigation of prion strain properties with carboxyl-terminal truncation specific antibodies in animal models

    Synucleinopathies are a group of neurodegenerative disorders characterized by the presence of misfolded α-Synuclein (αSyn) in the brain. These...

    Grace M. Lloyd, Stephan Quintin, ... Benoit I. Giasson in Acta Neuropathologica Communications
    Article Open access 10 June 2024
  19. RAB7A GTPase Is Involved in Mitophagosome Formation and Autophagosome–Lysosome Fusion in N2a Cells Treated with the Prion Protein Fragment 106–126

    Failed communication between mitochondria and lysosomes causes dysfunctional mitochondria, which may induce mitochondria-related neurodegenerative...

    Zhi** Li, Mengyu Lai, ... Lifeng Yang in Molecular Neurobiology
    Article 30 November 2022
  20. New developments in prion disease research

    Sabine Gilch, Hermann M. Schätzl in Cell and Tissue Research
    Article 15 March 2023
Did you find what you were looking for? Share feedback.